Abstract
Exemestane (EXE) is an irreversible steroidal aromatase inhibitor mainly used as an adjuvant endocrine therapy for postmenopausal women suffering from breast cancer. Besides inhibiting aromatase activity, EXE has multiple biological functions, such as antiproliferation, anti-inflammatory, and antioxidant activities which are all involved in hepatic fibrosis. Therefore, we investigated the role of EXE during the progress of hepatic fibrosis. The effect of EXE on liver injury and fibrosis were assessed in two hepatic fibrosis rat models, which were induced by either carbon tetrachloride (CCl4) or bile duct ligation (BDL). The influence of EXE treatment on activation and proliferation of primary rat hepatic stellate cells (HSCs) was observed in vitro. The results showed that EXE attenuated the liver fibrosis by decreasing the collagen deposition and α-SMA expression in vivo and inhibited the activation and proliferation of primary rat HSCs in vitro. Additionally, EXE promoted the secretion of antifibrotic and anti-inflammatory cytokine IL-10 in vivo and in HSC-T6 culture media. In conclusion, our findings reveal a new function of EXE on hepatic fibrosis and prompted its latent application in liver fibrotic-related disease.
References
Sep 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·E di SalleR C Coombes
Mar 3, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M YasudaS Ito
Mar 3, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D M Bissell
Aug 10, 1999·Journal of Gastroenterology and Hepatology·D Li, S L Friedman
Mar 19, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Helen L Reeves, Scott L Friedman
Mar 19, 2003·Liver International : Official Journal of the International Association for the Study of the Liver·Ichiro Shimizu
Apr 28, 2004·World Journal of Gastroenterology : WJG·Qing-Hua LiuHan-Ming Lu
Aug 25, 2005·Methods in Molecular Medicine·Ralf Weiskirchen, Axel M Gressner
Nov 3, 2005·Nature Clinical Practice. Gastroenterology & Hepatology·Scott L Friedman
Oct 31, 2006·World Journal of Gastroenterology : WJG·Yoshiyuki TakaharaNorifumi Kawada
Mar 21, 2007·Gut·Henry VölzkeMartina Dören
Apr 3, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Ichiro Shimizu, Susumu Ito
May 9, 2007·Gastroenterology·Samuele De MinicisRobert F Schwabe
Aug 5, 2008·Breast Cancer Research and Treatment·Selma MasriShiuan Chen
Nov 26, 2009·Molecular Cancer·Angelos KoutrasHaralabos Kalofonos
Jul 17, 2010·Oncology·Shiou-Hwei Yeh, Pei-Jer Chen
Aug 23, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Donna L WhiteHashem B El-Serag
May 1, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yang-Gun SuhWon-Il Jeong
Jul 24, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Wolfram Goessling
Aug 23, 2012·PloS One·Cristina AmaralNatércia Teixeira
Jul 24, 2013·Journal of Gastroenterology and Hepatology·Hyon-Seung Yi, Won-Il Jeong
Nov 6, 2013·Proceedings of the National Academy of Sciences of the United States of America·Hua Liu, Paul Talalay
Jan 18, 2014·Endocrine-related Cancer·Kathleen Van AstenRobert Paridaens
Jun 22, 2016·The Breast : Official Journal of the European Society of Mastology·A Y AltinokN S Bese